TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33243443

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus EP-100 (80 mg/m2 paclitaxel intravenously plus 30 mg/m2 EP-100 intravenously)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Paclitaxel alone (80 mg/m2 intravenously)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus EP-100
Number of subjects: 44

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 44
Study: 34103439

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 31
Study: 33407801

Group type: EXPERIMENTAL
Intervention: upadacitinib 7.5 mg QD
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg QD
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: upadacitinib 30 mg QD
Number of subjects: 197

Group type: COMPARATOR
Intervention: upadacitinib (all doses) after switching from placebo
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg and 30 mg
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: upadacitinib 7.5 mg and 15 mg
Number of subjects: 197
Study: 36383809

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (bolus 0.5 mcg/kg followed by 0.7 mcg/kg/h)
Number of subjects: 24
Study: 32198604

Group type: EXPERIMENTAL
Intervention: Musicians
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonmusicians
Number of subjects: 0
Study: 34119443

Group type: EXPERIMENTAL
Intervention: Guidelines-based clinical pathway of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32819780

Group type: EXPERIMENTAL
Intervention: LSVT LOUD
Number of subjects: 8
Study: 33839465

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids and potassium thiocyanate with standard treatment of SCA (test group, N = 14)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard treatment only (control group, N = 7)
Number of subjects: 21
Study: 33135390

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg with famotidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemborexant 10 mg
Number of subjects: 0
Study: 36192754

Group type: EXPERIMENTAL
Intervention: TEAMWork mobile application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informational paper booklet
Number of subjects: 0
Study: 34412739

Group type: EXPERIMENTAL
Intervention: Potential clinically significant drug-drug interactions (DDIs) detected using Lexicomp software
Number of subjects: 1211
Study: 32583957

Group type: EXPERIMENTAL
Intervention: Umibecestat (orally active β‐secretase inhibitor)
Number of subjects: 372
Study: 33353440

Group type: EXPERIMENTAL
Intervention: BeFAST (sports skills movement training)
Number of subjects: 20

Group type: COMPARATOR
Intervention: BeSTRONG (lower limb strength training)
Number of subjects: 20
Study: 36066332

Group type: EXPERIMENTAL
Intervention: 12-week group-based rehabilitation program comprising goal setting, physical exercise, psychoeducation, individual follow-up consultations, and peer support.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise component of the rehabilitation program.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Individual consultations as part of the rehabilitation program.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peer support as part of the rehabilitation program.
Number of subjects: 60
Study: 32240832

Group type: EXPERIMENTAL
Intervention: Antibiotics (n = 85) for 7 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (n = 95) for 7 days
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Antibiotics (n = 85)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (n = 95)
Number of subjects: 180
Study: 32661193

Group type: EXPERIMENTAL
Intervention: Computer-generated SMS intervention (2 messages per week for 3 months)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard of care diabetic care (control group)
Number of subjects: 320
Study: 35960214

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone (BUP-NX)
Number of subjects: 570
Study: 34063455

Group type: EXPERIMENTAL
Intervention: Bevacizumab (from GOG218 and ICON7 studies)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib (from SOLO-1 study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Niraparib (from PRIMA study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rucaparib (from ongoing ATHENA study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (PD-1 and PD-L1 antibodies)
Number of subjects: 0
Study: 36216620

Group type: EXPERIMENTAL
Intervention: Educational time-out intervention
Number of subjects: 8
Study: 34193480

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine 0.25 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 80
Study: 32962684

Group type: COMPARATOR
Intervention: Usual practice, repeated assessments and a self-monitoring app
Number of subjects: 2142

Group type: EXPERIMENTAL
Intervention: Generic cognitive-behavioral therapy self-help in app
Number of subjects: 2142

Group type: EXPERIMENTAL
Intervention: Personalised EC self-help in app
Number of subjects: 2142
Study: 36206153

Group type: EXPERIMENTAL
Intervention: High-Flux Hemodialysis (HF-HD) with dialyzer surface area 2.6m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Online post-dilution Hemodiafiltration (HDF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: High-Flux Hemodialysis (HF-HD)
Number of subjects: 25
Study: 34220825

Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation (FMT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 32891271

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Comparison between Tai Chi and Home exercise
Number of subjects: 28
Study: 33908167

Group type: EXPERIMENTAL
Intervention: Photography-aided behavioural intervention
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 55
Study: 32147372

Group type: EXPERIMENTAL
Intervention: Total adverse childhood experience score
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 565
Study: 36463629

Group type: EXPERIMENTAL
Intervention: Attention Control Training Program for Social Anxiety (ACTP‐SA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham-intervention control condition
Number of subjects: 30
Study: 34023405

Group type: EXPERIMENTAL
Intervention: Patients with FOG
Number of subjects: 75

Group type: COMPARATOR
Intervention: Patients without FOG
Number of subjects: 75
Study: 33001144

Group type: EXPERIMENTAL
Intervention: Oxymetazoline, 0.1%
Number of subjects: 304

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 304
Study: 34628447

Group type: EXPERIMENTAL
Intervention: HIIT + RT (3× per week, 12 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: HIIT + RT
Number of subjects: 17
Study: 33359106

Group type: EXPERIMENTAL
Intervention: Acetaminophen 500-mg tablet 45 minutes before reduction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35791295

Group type: EXPERIMENTAL
Intervention: Intranasal testosterone (NT) 11 mg TID
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone cypionate (TC) 200 mg ×2 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Subcutaneous testosterone pellets (TP) 800 mg
Number of subjects: 75
Study: 33038531

Group type: EXPERIMENTAL
Intervention: Circulating levels of soluble ST2 (sST2)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Diuretic efficiency (DE) calculated as net fluid output per 40 mg of furosemide equivalents
Number of subjects: 160
Study: 32421168

Group type: EXPERIMENTAL
Intervention: 1 reminder
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 1 reminder (adults 18-64 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders (adults 18-64 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders (adults 18-64 years)
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder (adults 18-64 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 1 reminder (male patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders (male patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders (male patients)
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder (male patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 1 reminder (non-Hispanic patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders (non-Hispanic patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders (non-Hispanic patients)
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder (non-Hispanic patients)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 1 reminder (not vaccinated in prior 2 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders (not vaccinated in prior 2 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders (not vaccinated in prior 2 years)
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder (not vaccinated in prior 2 years)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 1 reminder (including self-reported vaccinations)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 2 reminders (including self-reported vaccinations)
Number of subjects: 164205

Group type: EXPERIMENTAL
Intervention: 3 reminders (including self-reported vaccinations)
Number of subjects: 164205

Group type: COMPARATOR
Intervention: No reminder (including self-reported vaccinations)
Number of subjects: 164205
Study: 33170536

Group type: EXPERIMENTAL
Intervention: SMS rs‐EPI
Number of subjects: 134

Group type: COMPARATOR
Intervention: rs‐EPI
Number of subjects: 134
Study: 32691548

Group type: EXPERIMENTAL
Intervention: Optimization of operative procedure using Two Chief Surgeons Model and anticlockwise operative process
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group with no specific operative procedure
Number of subjects: 146

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 146
Study: 33952155

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 72
Study: 33386053

Group type: EXPERIMENTAL
Intervention: Immediate loading protocol (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed loading protocol (Group B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 33724104

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 120
Study: 34587941

Group type: EXPERIMENTAL
Intervention: Choline-stabilized orthosilicic acid (CS-OSA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 34424265

Group type: EXPERIMENTAL
Intervention: Newborn genomic sequencing (nGS) report of childhood‐onset conditions and highly actionable adult‐onset conditions
Number of subjects: 519

Group type: COMPARATOR
Intervention: Standard newborn screening and a family history report (control group)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Newborn genomic sequencing (nGS)
Number of subjects: 519
Study: 36223105

Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure goal of less than 120 mm Hg)
Number of subjects: 9361
Study: 33411585

Group type: EXPERIMENTAL
Intervention: Vincristine/Dexamethasone pulses every 4 weeks (VCR/DEX4)
Number of subjects: 9229

Group type: COMPARATOR
Intervention: Vincristine/Dexamethasone pulses every 12 weeks (VCR/DEX12)
Number of subjects: 9229

Group type: EXPERIMENTAL
Intervention: Weekly oral methotrexate at a dose of 20 mg/m2 (MTX20)
Number of subjects: 9229

Group type: COMPARATOR
Intervention: Weekly oral methotrexate at a dose of 40 mg/m2 (MTX40)
Number of subjects: 9229
Study: 32898176

Group type: EXPERIMENTAL
Intervention: Low-energy total diet replacement (TDR) programme delivered by lay counsellors
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Support and guidance from the counsellor
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rapid weight loss experienced by patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall experience of the TDR programme
Number of subjects: 12
Study: 34763950

Group type: EXPERIMENTAL
Intervention: HAPIBEV™ vaccine
Number of subjects: 467

Group type: COMPARATOR
Intervention: Havrix® vaccine
Number of subjects: 467
Study: 33019730

Group type: EXPERIMENTAL
Intervention: Residents with stroke prior to admission
Number of subjects: 643

Group type: COMPARATOR
Intervention: Residents without stroke prior to admission
Number of subjects: 643
Study: 35473409

Group type: EXPERIMENTAL
Intervention: Exercise (cycle ergometer)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 33504188

Group type: EXPERIMENTAL
Intervention: IVT+MT
Number of subjects: 2002

Group type: COMPARATOR
Intervention: direct MT
Number of subjects: 2002
Study: 35710560

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32885352

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (HDD)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard prednisone (PDN)
Number of subjects: 211
Study: 35364022

Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 1 year
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 2 years
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 1 year (two-dose primary schedule)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 2 years (two-dose primary schedule)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: CYD-TDV booster (1 year or 2 years)
Number of subjects: 1050
Study: 34526950

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (twice daily for 5 days, blood pressure cuff inflated to 20 mmHg above systolic blood pressure, up to 180 mmHg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group (blood pressure cuff inflated to 30 mmHg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (NIHSS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (PHQ-9)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 40
Study: 32347270

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 1 gram (830 mg of GTP) with quercetin (Q) 800 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (GT + PL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) with quercetin (Q)
Number of subjects: 31
Study: 33544719

Group type: EXPERIMENTAL
Intervention: log-GGT
Number of subjects: 709
Study: 32492734

Group type: EXPERIMENTAL
Intervention: Yoga with blood flow restriction bands
Number of subjects: 20

Group type: COMPARATOR
Intervention: Yoga without blood flow restriction bands
Number of subjects: 20
Study: 33673741

Group type: EXPERIMENTAL
Intervention: Well-being (WB) spectrum psychological traits (PT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reverse well-being traits like neuroticism
Number of subjects: 0
Study: 34412860

Group type: EXPERIMENTAL
Intervention: Stand group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sit group
Number of subjects: 96
Study: 32196390

Group type: EXPERIMENTAL
Intervention: Active Communication Education (ACE) programme
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cognitive stimulation programme
Number of subjects: 66
Study: 616474479

Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study: 33770276

Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy (RPD)
Number of subjects: 130
Study: 34625083

Group type: EXPERIMENTAL
Intervention: Vigorous leisure-time physical activity (LPA)
Number of subjects: 1464

Group type: COMPARATOR
Intervention: Moderate leisure-time physical activity (LPA)
Number of subjects: 1464
Study: 32359392

Group type: EXPERIMENTAL
Intervention: Germination experiment at 0, -4 bar and -8 bar levels
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: IS10 and IS15 primers
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Chromosome analysis
Number of subjects: 3
Study: 36371213

Group type: EXPERIMENTAL
Intervention: Auditory rhythmical cueing (ARC) gait and balance training programme
Number of subjects: 59

Group type: COMPARATOR
Intervention: Training programme without ARC (control)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 33486572

Group type: EXPERIMENTAL
Intervention: Co-administration of 10 g viscous fiber, 60 g white chia seeds, 1.5 g American ginseng, and 0.75 g Korean ginseng extracts
Number of subjects: 104

Group type: COMPARATOR
Intervention: Energy and fiber-matched control (53 g oat bran, 25 g inulin, 25 g maltodextrin, and 2.25 g wheat bran)
Number of subjects: 104
Study: 33025690

Group type: EXPERIMENTAL
Intervention: 15 mg/kg IV acetaminophen
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 32441473

Group type: EXPERIMENTAL
Intervention: Semaglutide 2.4 mg once weekly subcutaneously
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5000
Study: 34453286

Group type: EXPERIMENTAL
Intervention: Higher analytic thinking levels (measured by the Cognitive Reflection Test)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Claims about COVID-19 (half debunked misinformation, half endorsed by public health agencies)
Number of subjects: 742
Study: 33332726

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.1 mg/kg and 1 mg/kg) for 10 days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Propranolol (30 mg/kg) as positive control
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal saline (10 ml/kg) as negative control
Number of subjects: 84
Study: 32075823

Group type: EXPERIMENTAL
Intervention: Community-based doula support (CBD)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard labour support
Number of subjects: 200
Study: 35094120

Group type: EXPERIMENTAL
Intervention: Combined intervention (breathing exercises + manual therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Breathing exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 34256550

Group type: EXPERIMENTAL
Intervention: 34 kcal of a fructose solution daily for 5 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water for the first 5 days followed by 34 kcal fructose solution
Number of subjects: 6
Study: 32057907

Group type: EXPERIMENTAL
Intervention: Immediate release formulations containing a model drug of BCS class III
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: AGS with programmable 'pyloric' valve
Number of subjects: 4

Group type: COMPARATOR
Intervention: Conventional dissolution method
Number of subjects: 4
Study: 34618687

Group type: EXPERIMENTAL
Intervention: PR3+ B cells in participants with PR3-AAV
Number of subjects: 154
Study: 32965655

Group type: EXPERIMENTAL
Intervention: Cal/BD foam applied twice weekly for up to 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Foam vehicle applied twice weekly for up to 52 weeks (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cal/BD foam (rescue therapy) applied once daily for 4 weeks on active areas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cal/BD foam applied twice weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Foam vehicle applied twice weekly (control)
Number of subjects: 0
Study: 36210015

Group type: EXPERIMENTAL
Intervention: Soft drink prime (participants saw images with cola)
Number of subjects: 964

Group type: EXPERIMENTAL
Intervention: Water prime (participants saw images with water)
Number of subjects: 964

Group type: COMPARATOR
Intervention: Control (participants saw images with no drink)
Number of subjects: 964
Study: 33423549

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 86
Study: 35135323

Group type: EXPERIMENTAL
Intervention: Second cohort (endovascular treatment)
Number of subjects: 1692
Study: 34487920

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 10 J/cm2 plus conventional treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 8 J/cm2 plus conventional treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 4 J/cm2 plus conventional treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo LLLT plus conventional treatment
Number of subjects: 80
Study: 33844276

Group type: EXPERIMENTAL
Intervention: Providers without advanced degrees
Number of subjects: 182

Group type: COMPARATOR
Intervention: Providers with advanced degrees
Number of subjects: 182
Study: 36460015

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 1082

Group type: EXPERIMENTAL
Intervention: Early stylet removal
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Late stylet removal
Number of subjects: 1082
Study: 32112254

Group type: EXPERIMENTAL
Intervention: 3D imaging system
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2D imaging system
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 2D/3D transition
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 3D/2D transition
Number of subjects: 26
Study: 36136791

Group type: EXPERIMENTAL
Intervention: Enhanced incentive (EI) condition
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard incentive (SI) condition
Number of subjects: 38
Study: 34559101

Group type: EXPERIMENTAL
Intervention: Yijinjing exercise for 4 months in addition to conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment with maintained current lifestyle
Number of subjects: 0